Aarti Drugs Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding scheduled meetings with analysts and institutional investors.
The disclosure is made pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
- Date: June 23, 2026
- Time: 10:00 AM to 3:30 PM
- Nature: Group Meeting
- Venue: Tarapur, Maharashtra
Discussion Parameters
Company officials will meet with investors/participants, with discussions based exclusively on publicly available information. The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during these interactions.
Contingency Note
The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of either the host or the company.